Medicxi Ventures Management (Jersey) Ltd CNTA — CENTESSA PHARMACEUTICALS PLC

Ownership history in Medicxi Ventures Management (Jersey) Ltd  ·  20 quarters on record

AI Ownership Summary

Medicxi Ventures Management (Jersey) Ltd reported CENTESSA PHARMACEUTICALS PLC (CNTA) in 20 quarterly 13F filings from 2023 Q4 through 2026 Q1. Peak portfolio weight reached 80.76% in 2026 Q1. The latest visible filing shows CNTA at 80.76% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings. Older history is available after unlock; the visible window still shows the most recent pattern.

What this CNTA ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was Medicxi Ventures Management (Jersey) Ltd's position in CENTESSA PHARMACEUTICALS PLC, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q1

CNTA was reported at 80.76% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
80.76% in 2026 Q1

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2023 Q4 to 2026 Q1

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

CNTA stock page Medicxi Ventures Management (Jersey) Ltd fund profile Medicxi Ventures Management (Jersey) Ltd full holdings
How Medicxi Ventures Management (Jersey) Ltd held CNTA — position size vs. price
% of Fund (quarterly)    CNTA price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 10 quarters  ▾
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q1 UNCHANGED — — — 19,963,157 — 0% 80.76% $792.9M 2026-04-21 $39.49
2025 Q4 UNCHANGED — — — 19,963,157 — 0% 59.80% $499.3M 2026-01-23 $25.27
2025 Q3 UNCHANGED — — — 19,963,157 — 0% 65.03% $484.1M 2025-10-17 $23.02
2025 Q2 UNCHANGED — — — 19,963,157 — 0% 61.40% $262.3M 2025-07-08 $13.56
2025 Q1 UNCHANGED — — — 19,963,157 — 0% 65.59% $287.1M 2025-04-11 $11.57
2024 Q4 UNCHANGED — — — 19,963,157 — 0% 63.20% $334.4M 2025-01-23 $16.28
2024 Q3 UNCHANGED — — — 19,963,157 — 0% 60.35% $319.2M 2024-10-15 $16.09
2024 Q2 UNCHANGED — — — 19,963,157 — 0% 53.77% $180.3M 2024-07-16 $9.93
2024 Q1 UNCHANGED — — — 19,963,157 — 0% 50.22% $225.6M 2024-04-15 $10.78
2023 Q4 UNCHANGED — — — 19,963,157 — 0% 53.64% $158.9M 2024-02-01 $8.01
10 older quarters hidden  —  Sign in free or upgrade to Premium to see full history

🏢 Other funds also holding CNTA

As of 2026 Q1 — sorted by position size

Index Venture Life Associates VI Ltd 3Y 100.0% Foresite Capital Management VI LLC 11.77% EcoR1 Capital, LLC 3Y 7Y 10.11% 5AM Venture Management, LLC 3Y 6.41% First Light Asset Management, LLC 3Y 7Y 5.56% TCG Crossover Management, LLC 3Y 4.87% Spruce Street Capital LP 4.68% Avoro Capital Advisors LLC 3Y 7Y 4.47% Logos Global Management LP 3Y 4.21% PERCEPTIVE ADVISORS LLC 3Y 7Y 4.09%

FAQ About Medicxi Ventures Management (Jersey) Ltd and CNTA

These are the practical questions this page is built to answer before you even open the full history table.

How long has Medicxi Ventures Management (Jersey) Ltd reported owning CNTA?

Medicxi Ventures Management (Jersey) Ltd reported CNTA across 10 quarterly 13F filings, from 2023 Q4 through 2026 Q1.

What was the largest reported CNTA position in Medicxi Ventures Management (Jersey) Ltd's portfolio?

The largest reported portfolio weight for CNTA was 80.76% in 2026 Q1.

What is the latest reported CNTA position on this page?

The most recent filing on this page is 2026 Q1, when Medicxi Ventures Management (Jersey) Ltd reported 19,963,157 shares, equal to 80.76% of portfolio, with an estimated market value of $792.9M.

What does the chart on this CNTA ownership page compare?

The chart compares Medicxi Ventures Management (Jersey) Ltd's quarterly CNTA portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did Medicxi Ventures Management (Jersey) Ltd time their CNTA position?

Based on 13F filing dates vs. subsequent CNTA price moves, Medicxi Ventures Management (Jersey) Ltd correctly timed 0 out of 3 reported position changes (0%). The annualised alpha on CNTA relative to SPY over the holding period was +3.1%.

← Back to Medicxi Ventures Management (Jersey) Ltd Holdings